Pipeline & Growth Roadmap

Where Our Pipeline Is Headed

The Terrain pipeline is built through identifying late-stage products with strong clinical profiles and unmet U.S. market demand, extending our distribution infrastructure with the market access needed for commercialization, and launching them through our established network of independent retail and specialty pharmacies, medical practices, and specialty wholesalers.

2026 Snapshots

Q2 2026

Meloxicam 15mg Tablets
Anticonvulsant capsules

Q3 2026

Lidocaine Patch (PHN)

Q4 2026

SNRI capsules
Antibiotic tablets
NSAID capsules
PPI capsules

Q1 2027

LidoPro® Patch XR
NSAID solution
Lidocaine 5% ointment

Core Pipeline Grid

Focus Area

Near-Term Actions

Strategic Goal

Pain & Musculoskeletal

Launch NSAID, lidocaine, and other pain relief patches and gels with partners in 2026

Establish TerrainRx as the  go to non-opioid pain platform

Adjunctive Care

Launch sleep aid patch with partner and stool softener softgel internally in 2026

Specialty and dosage form diversification

Controlled Release DIA Tech

Advance next gen delivery matrix with enhanced permeation

Enable higher strength Rx patches while reducing API load

Pipeline Licensing

Acquire select ANDAs and 505(b)(2) assets

Add fast track revenue while leveraging existing channels

Data Driven Distribution

Expand wholesaler and prescriber network footprint

Deepen market visibility and accelerate product pull through

Partnership Capital

Deploy co-development funds with CMOs & brand owners

Share risk, speed scale up, and  secure demand for new capacity

How We Move Ideas to Market

Evaluate

Technical & commercial due diligence, CQA mapping, pathway selection.

Execute

Formulation lock, tech transfer, regulatory filing, channel staging.

Expand

Line extensions, new packs, and channel deepening for life cycle extension.

Growth, Line Extension, or Liquidity

Option for TerrainRx to purchase asset or royalty buy out of mature assets.

Partner Touchpoints

Stage

Ideal Partner Contribution

TerrainRx Contribution

Concept / Asset Review

Dossier, analytics, cost targets

Market mapping, regulatory gap analysis

Development & Scale Up

API / tech package, facility access

Formulation IP, CMC, capital, validation support

Launch & Growth

Field insights, demand signals

Distribution, reimbursement, performance reporting